PULMONARY EMBOLISM
Mr. ANILKUMAR B R , LECTURER , MEDICAL-SURGICAL
NURSING
Definition
 Pulmonary embolism (PE) refers to the
obstruction of the Pulmonary artery or one of
its branches by a thrombus (or thrombi) that
originates somewhere in the venous system or
right side of the heart.
Pulmonary embolism
 Pulmonary embolism is a common disorder
and often is associated with trauma, surgery
(orthopedic, major abdominal, pelvic,
gynecologic) pregnancy, heart failure, age
older than 50 years and prolonged immobility.
PULMONARY EMBOLISM
Risk factors for Pulmonary embolism
A) Venous stasis (slowing of
blood flow in veins)
1) Prolonged immobilization (especially
postoperative)
2) prolonged periods of sitting or traveling
3) varicose veins
4) Spinal cord injury
Hypercoagulability ( due to release of tissue
thromboplastin after injury /surgery)
1) Injury
2) Tumor ( pancreatic, GIT, Genitourinary, breast and
lung tumor)
3) Increased platelet count (polycythemia)
Venous endothelial disease
1) Thrombophlebitis
2) vascular diseases
3) foreign bodies (iv/central venous catheters)
Certain disease states (combination of states,
coagulation Alterations, and venous Injury)
1) Heart disease (Heart failure)
2) Trauma ( Fracture of hip, pelvis, vertebra, lower
extremities)
3) Post operative state /postpartum period
4) Diabetes mellitus and COPD
Other predisposing factors
1) Advanced age
2) Obesity
3) Pregnancy
4) Oral contraceptive use
5) Constrictive clothing
6) History of previous PE
Clinical manifestations
 Clinical manifestations or symptoms depends
on the size of the thrombus :
1) DYSPNEA is the most frequent symptom
2) Tachypnea (very rapid respiratory rate) is the most
frequent sign.
Continue… ..
 Chest pain is common and is usually sudden and
pleurtic in origin.
 It may be substernal and may mimic angina
pectoris or may Myocardial infraction.
Other symptoms include
 Anxiety
 Fever, Tachycardia, apprehension, cough,
diaphoresis, hemoptysis and syncope.
Assessment and diagnostic findings
 Death from PE commonly occurs with in one hour
after the onset of symptoms :therefore early
recognition and diagnosis are priorities, a
diagnostic workup is performed to rule out other
diseases.
Continue ..
The initial diagnostic workup includes
1) Chest x-ray
2) ECG
3) Peripheral vascular studies
4) Arterial blood gas analysis (abg)
5) ventilation perfusion scan and Pulmonary
angiography
Medical management
 Because PE is often a medical emergency,
emergency management is of primary concern.
After emergency measures have been initiated and
the patient is stabilized, the treatment goal is to
dissolve the existing emboli and prevent new ones
from forming.
Treatment may include a variety of
modalities
 General measures to improve respiratory and
vascular status.
 Anticoagulation therapy
 Thrombolytic therapy
 Surgical intervention
Emergency management
 Massive PE is a life – threatening emergency
 The immediate objective is to stabilize the
cardiopulmonary system.
Emergency management consists of the
following actions
 Nasal oxygen is administered immediately to relive
hypoxemia, respiratory distress, and central
cyanosis.
 Establish IV Lines.
 Vasopressors ,inotropic agents such as dopamine
and anti dysrhythmic agents may be indicated to
support circulation if the client is unstable.
 Perfusion scan, Hemodynamic monitoring and ABG.
Continue
 Hypotension is treated by a slow infusions of
dobutamine.
 Continue monitoring ECG
 Blood is drawn for serum electrolytes, CBC etc
Continue
 If clinical assessment and ABG analysis indicate
the need, the patient is intubated and placed on a
mechanical ventilator.
 If the patient has suffered massive embolism and
is hypotensive, an indwelling urinary catheter is
inserted to monitor urinary output.
Continue
 Small doses of IV Morphine or sedative are
administered to relive patient anxiety.
General management
 Measure are initiated to improve respiratory and
vascular status.
 Oxygen therapy
 Use of elastic compression stocking or intermittent
pneumatic leg compression devices reduces
venous stasis.
 Elevating the leg above the level of heart
Elastic compression stocking
Intermittent pneumatic leg compression
devices
Pharmacologic therapy
 Anticoagulation therapy: (heparin, warfarin
Sodium) has traditionally been the primary method
for managing acute deep venous thrombosis and
PE.
Thrombolytic therapy
 Thrombolytic therapy: (urokinase, streptokinase,
alteplase and reteplase)
 Thrombolytic therapy resolves the thrombi or
emboli more quickly and restores more normal
Hemodynamic functioning of the Pulmonary
circulation, thereby reducing Pulmonary
hypertension and improving Perfusion,
Oxygenation, and cardiac output.
Continue
 Bleeding is a significant side effect.
Contraindications to Thrombolytic therapy include
a CVA within the past 2 months, or other active
intracranial processes, active bleeding, surgery
within 10 days of the Thrombolytic therapy, recent
delivery or labor and sever hypertension.
Continue
 Before start Thrombolytic therapy, INR. PTT ,
HEMATOCRIT, AND PLATELET counts are
obtained.
 Heparin is stopped prior to administration of a
Thrombolytic therapy.
 During therapy, all but essential invasive procedure
are avoidied because of potential bleeding.
Surgical management
 A surgical “EMBOLECTOMY” is rarely performed
but may be indicated if the patient has a massive
PE. Or Hemodynamic instability or if there are
contraindications to Thrombolytic therapy.
Nursing management patient with PE
 Minimize the risk of Pulmonary embolism
 Preventing thrombus formation ( early ambulation,
active and passive exercise, pumping exercise, not
to sit or lie Prolonged periods, avoid cross leg and
Constrictive clothing and IV cath and central line
cath should not be left in place for prolonged
periods)
Assessing potential for Pulmonary
embolism
 All patients are assessed and evaluated for risk
factors for thrombus formation and Pulmonary
embolism.
 Careful assessment of the patient’s health history,
family history and medication record
 Daily basis asked about patient pain or discomfort
in the exterminates and evaluate for warmth,
Redness, and Inflammation.
Monitoring Thrombolytic therapy
 Carefully and close monitoring of Thrombolytic
therapy and Anticoagulation therapy.
 During Thrombolytic infusions, while the patient
remains on bed rest, vital signs are assessed
every 2 hours and invasive procedure are avoided.
 Test to determine INR and PTT are performed
every 3 hours
Management of pain
 Adequate management of chest pain is essential
 A semi – fowler‘s Postion
 Administer opioid analgesic as prescribed for
severe chest pain
Managing oxygen therapy
 Pulseoximetry
 Deep breathing and incentive spirometry
 nebulizer therapy, percussion and Postral
drainage may be used for management of
secretions.
Reliving anxiety
Monitoring for complications
 Bleeding as a result of thrombolytic therapy
 Cardiogenic shock
 Pulmonary hypertension, cur pulmonale
 Respiratory failure
Providing post operative care
 Pulmonary artery pressure
 Urinary output
Prevention of Pulmonary embolism
 For patients at risk for PE, the most effective
approach for prevention is to prevent DVT (deep
venous thrombosis).
 Active leg exercise to avoid venous stasis.
 Early ambulation is necessary.
 Use elastic compression stocking.
 Anticoagulation therapy may be prescribed for
patients who are older than 40 years of age.
 Heparin may administered before going to surgery
especially elective abdominal and thoracic surgery
 Use sequential compression devices (SCD,s)

Pulmonary embolism

  • 1.
    PULMONARY EMBOLISM Mr. ANILKUMARB R , LECTURER , MEDICAL-SURGICAL NURSING
  • 2.
    Definition  Pulmonary embolism(PE) refers to the obstruction of the Pulmonary artery or one of its branches by a thrombus (or thrombi) that originates somewhere in the venous system or right side of the heart.
  • 3.
  • 4.
     Pulmonary embolismis a common disorder and often is associated with trauma, surgery (orthopedic, major abdominal, pelvic, gynecologic) pregnancy, heart failure, age older than 50 years and prolonged immobility.
  • 5.
  • 6.
    Risk factors forPulmonary embolism A) Venous stasis (slowing of blood flow in veins) 1) Prolonged immobilization (especially postoperative) 2) prolonged periods of sitting or traveling 3) varicose veins 4) Spinal cord injury
  • 7.
    Hypercoagulability ( dueto release of tissue thromboplastin after injury /surgery) 1) Injury 2) Tumor ( pancreatic, GIT, Genitourinary, breast and lung tumor) 3) Increased platelet count (polycythemia)
  • 8.
    Venous endothelial disease 1)Thrombophlebitis 2) vascular diseases 3) foreign bodies (iv/central venous catheters)
  • 9.
    Certain disease states(combination of states, coagulation Alterations, and venous Injury) 1) Heart disease (Heart failure) 2) Trauma ( Fracture of hip, pelvis, vertebra, lower extremities) 3) Post operative state /postpartum period 4) Diabetes mellitus and COPD
  • 10.
    Other predisposing factors 1)Advanced age 2) Obesity 3) Pregnancy 4) Oral contraceptive use 5) Constrictive clothing 6) History of previous PE
  • 11.
    Clinical manifestations  Clinicalmanifestations or symptoms depends on the size of the thrombus : 1) DYSPNEA is the most frequent symptom 2) Tachypnea (very rapid respiratory rate) is the most frequent sign.
  • 12.
    Continue… ..  Chestpain is common and is usually sudden and pleurtic in origin.  It may be substernal and may mimic angina pectoris or may Myocardial infraction.
  • 13.
    Other symptoms include Anxiety  Fever, Tachycardia, apprehension, cough, diaphoresis, hemoptysis and syncope.
  • 14.
    Assessment and diagnosticfindings  Death from PE commonly occurs with in one hour after the onset of symptoms :therefore early recognition and diagnosis are priorities, a diagnostic workup is performed to rule out other diseases.
  • 15.
    Continue .. The initialdiagnostic workup includes 1) Chest x-ray 2) ECG 3) Peripheral vascular studies 4) Arterial blood gas analysis (abg) 5) ventilation perfusion scan and Pulmonary angiography
  • 16.
    Medical management  BecausePE is often a medical emergency, emergency management is of primary concern. After emergency measures have been initiated and the patient is stabilized, the treatment goal is to dissolve the existing emboli and prevent new ones from forming.
  • 17.
    Treatment may includea variety of modalities  General measures to improve respiratory and vascular status.  Anticoagulation therapy  Thrombolytic therapy  Surgical intervention
  • 18.
    Emergency management  MassivePE is a life – threatening emergency  The immediate objective is to stabilize the cardiopulmonary system.
  • 19.
    Emergency management consistsof the following actions  Nasal oxygen is administered immediately to relive hypoxemia, respiratory distress, and central cyanosis.  Establish IV Lines.  Vasopressors ,inotropic agents such as dopamine and anti dysrhythmic agents may be indicated to support circulation if the client is unstable.  Perfusion scan, Hemodynamic monitoring and ABG.
  • 20.
    Continue  Hypotension istreated by a slow infusions of dobutamine.  Continue monitoring ECG  Blood is drawn for serum electrolytes, CBC etc
  • 21.
    Continue  If clinicalassessment and ABG analysis indicate the need, the patient is intubated and placed on a mechanical ventilator.  If the patient has suffered massive embolism and is hypotensive, an indwelling urinary catheter is inserted to monitor urinary output.
  • 22.
    Continue  Small dosesof IV Morphine or sedative are administered to relive patient anxiety.
  • 23.
    General management  Measureare initiated to improve respiratory and vascular status.  Oxygen therapy  Use of elastic compression stocking or intermittent pneumatic leg compression devices reduces venous stasis.  Elevating the leg above the level of heart
  • 24.
  • 25.
    Intermittent pneumatic legcompression devices
  • 27.
    Pharmacologic therapy  Anticoagulationtherapy: (heparin, warfarin Sodium) has traditionally been the primary method for managing acute deep venous thrombosis and PE.
  • 28.
    Thrombolytic therapy  Thrombolytictherapy: (urokinase, streptokinase, alteplase and reteplase)
  • 29.
     Thrombolytic therapyresolves the thrombi or emboli more quickly and restores more normal Hemodynamic functioning of the Pulmonary circulation, thereby reducing Pulmonary hypertension and improving Perfusion, Oxygenation, and cardiac output.
  • 30.
    Continue  Bleeding isa significant side effect. Contraindications to Thrombolytic therapy include a CVA within the past 2 months, or other active intracranial processes, active bleeding, surgery within 10 days of the Thrombolytic therapy, recent delivery or labor and sever hypertension.
  • 31.
    Continue  Before startThrombolytic therapy, INR. PTT , HEMATOCRIT, AND PLATELET counts are obtained.  Heparin is stopped prior to administration of a Thrombolytic therapy.  During therapy, all but essential invasive procedure are avoidied because of potential bleeding.
  • 32.
    Surgical management  Asurgical “EMBOLECTOMY” is rarely performed but may be indicated if the patient has a massive PE. Or Hemodynamic instability or if there are contraindications to Thrombolytic therapy.
  • 33.
    Nursing management patientwith PE  Minimize the risk of Pulmonary embolism  Preventing thrombus formation ( early ambulation, active and passive exercise, pumping exercise, not to sit or lie Prolonged periods, avoid cross leg and Constrictive clothing and IV cath and central line cath should not be left in place for prolonged periods)
  • 34.
    Assessing potential forPulmonary embolism  All patients are assessed and evaluated for risk factors for thrombus formation and Pulmonary embolism.  Careful assessment of the patient’s health history, family history and medication record  Daily basis asked about patient pain or discomfort in the exterminates and evaluate for warmth, Redness, and Inflammation.
  • 35.
    Monitoring Thrombolytic therapy Carefully and close monitoring of Thrombolytic therapy and Anticoagulation therapy.  During Thrombolytic infusions, while the patient remains on bed rest, vital signs are assessed every 2 hours and invasive procedure are avoided.  Test to determine INR and PTT are performed every 3 hours
  • 36.
    Management of pain Adequate management of chest pain is essential  A semi – fowler‘s Postion  Administer opioid analgesic as prescribed for severe chest pain
  • 37.
    Managing oxygen therapy Pulseoximetry  Deep breathing and incentive spirometry  nebulizer therapy, percussion and Postral drainage may be used for management of secretions.
  • 38.
  • 39.
    Monitoring for complications Bleeding as a result of thrombolytic therapy  Cardiogenic shock  Pulmonary hypertension, cur pulmonale  Respiratory failure
  • 40.
    Providing post operativecare  Pulmonary artery pressure  Urinary output
  • 41.
    Prevention of Pulmonaryembolism  For patients at risk for PE, the most effective approach for prevention is to prevent DVT (deep venous thrombosis).  Active leg exercise to avoid venous stasis.  Early ambulation is necessary.  Use elastic compression stocking.
  • 42.
     Anticoagulation therapymay be prescribed for patients who are older than 40 years of age.  Heparin may administered before going to surgery especially elective abdominal and thoracic surgery  Use sequential compression devices (SCD,s)